A Cost Utility Analysis of Amlodipine Compared with Angiotensin II Receptor Blockers in Preventing Stroke and Myocardial Infarction Among Hypertension Patients in the Philippines.


(SOC) vs SOC alone in the US health care setting. The objective of this analysis is to assess the cost-effectiveness of RDN in patients with TR-HTN from the Australian payer perspective. Methods: Geisler methods were largely retained but life tables, resource use, costs and discount rates were revised to reflect Australian parameters. Importantly, the… (More)
DOI: 10.1016/j.jval.2014.08.267


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.